Study Evaluating the Safety and the Efficacy of Combination of Atezolizumab, Tiragolumab and and Stereotactic Body Radiation Therapy in Patients With Oligometastatic Multiorgan (IMMUNOs-SBRT)
Phase 1
Recruiting
- Conditions
- Metastatic Bladder CancerMetastatic Non Small Cell Lung CancerMetastatic Renal Cell CarcinomaMetastatic Head and Neck Cancer
- Interventions
- Drug: Atezolizumab 60 MG/1 ML Intravenous Solution [TECENTRIQ]Drug: TiragolumabRadiation: Stereotactic body radiation therapy (SBRT)
- First Posted Date
- 2022-02-28
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 92
- Registration Number
- NCT05259319
- Locations
- 🇫🇷
Centre Georges François Leclerc (CGFL), Dijon, Bourgogne, France
Evaluation of Efficacy of Trifluridine/Tipiracil Plus an Anti-IL-1α True Human Antibody Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine
Phase 1
Recruiting
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Drug: trifluridine/tipiracil + placeboDrug: trifluridine/tipiracil + XB2001
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 160
- Registration Number
- NCT05201352
- Locations
- 🇫🇷
ICO Angers, Angers, France
🇫🇷Institut Sainte Catherine, Avignon, France
🇫🇷CHU Jean Minjoz, Besançon, France
Value of Information of Secondary dAta in ONCOGEnetics
- Conditions
- Secondary FundingsCancerGenetic Predisposition
- First Posted Date
- 2021-07-22
- Last Posted Date
- 2021-07-22
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 70
- Registration Number
- NCT04972409
- Locations
- 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
Modifications in Retinal Microvascularization With Targeted Anti-angiogenic Therapy in Colorectal Cancer
Not Applicable
Recruiting
- Conditions
- Colorectal Cancer
- Interventions
- Other: OCT- Angiographie
- First Posted Date
- 2021-07-07
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 30
- Registration Number
- NCT04952688
- Locations
- 🇫🇷
Centre Georges François Leclerc, Dijon, France
🇫🇷CHU de Dijon, Dijon, France
Assessment of Health Related Quality of Life in Women Who Underwent Breast Reconstruction After Radical Surgery
Recruiting
- Conditions
- Breast Cancer
- First Posted Date
- 2021-06-24
- Last Posted Date
- 2021-06-24
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 200
- Registration Number
- NCT04938505
- Locations
- 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
Mechanisms of Anti COVID-19 Humoral and Cellular Immune Response After Vaccination in a Sample of Patients and Salaried Staff From a French Anti-cancer Center
Not Applicable
Completed
- Conditions
- Cancer
- Interventions
- Biological: serology and ELISPOT testBiological: serology
- First Posted Date
- 2021-06-23
- Last Posted Date
- 2023-10-11
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 539
- Registration Number
- NCT04935528
- Locations
- 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
Immunomonitoring of Breast Cancer Patients During Systemic Treatment
Not Applicable
Recruiting
- Conditions
- Breast Cancer
- Interventions
- Other: blood sample
- First Posted Date
- 2021-06-14
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 150
- Registration Number
- NCT04925856
- Locations
- 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
🇫🇷CHRU Jean Minjoz, Besançon, France
Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma
Not Applicable
Active, not recruiting
- Conditions
- Adenocarcinoma of the Prostate
- Interventions
- Radiation: Stereotactic Radiotherapy with Linac MRI
- First Posted Date
- 2021-06-01
- Last Posted Date
- 2024-02-13
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 68
- Registration Number
- NCT04909294
- Locations
- 🇫🇷
Centre Georges François Leclerc, Dijon, France
Immuno Monitoring in Patient With Epithelial Ovarian Cancer Eligible to PARP Inhibitors
Active, not recruiting
- Conditions
- Ovarian Cancer
- Interventions
- Biological: blood samples
- First Posted Date
- 2020-12-19
- Last Posted Date
- 2023-12-07
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 50
- Registration Number
- NCT04675320
- Locations
- 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
🇫🇷CHRU Jean Minjoz, Besançon, France
Exome Analysis (Complexe vs Simple) to Help the Therapeutic Decision for the Precision Medicine
Phase 2
Recruiting
- Conditions
- Cancer
- Interventions
- Genetic: Exome analysis
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Centre Georges Francois Leclerc
- Target Recruit Count
- 2518
- Registration Number
- NCT04614480
- Locations
- 🇫🇷
CHRU Jean Minjoz, Besançon, France
🇫🇷Institut Bergonie, Bordeaux, France
🇫🇷CHU Amiens Picardie, Amiens, France
© Copyright 2025. All Rights Reserved by MedPath